User banner image
User avatar
  • admin

Posts

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study

VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”), a company focused...

Chemomab Reports New Positive Clinical Data at EASL 2025 Supporting Nebokitug’s Impact in Primary Sclerosing Cholangitis and Related Diseases

New Analyses of PSC Data from Phase 2 SPRING Trial Show that Treatment with Nebokitug Is Associated with Dose-Dependent and Significant Improvements in Multiple Inflammatory...

Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting

New data includes real-world analyses of VOQUEZNA-treated patients in the U.S. diagnosed with gastroesophageal reflux disease (GERD) FLORHAM PARK, N.J., April 28, 2025 (GLOBE NEWSWIRE)...

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s Drug

SARASOTA, FL, April 28, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel...

Appili Therapeutics Announces New Patents Granted for Commercial Stage Asset LIKMEZ®™

New patents provide additional composition of matter and methods of use claims, strengthening the protection for liquid oral taste-masked reformulation, LIKMEZ New subject matter listed...

WOORI FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F

SEOUL, South Korea, April 28, 2025 /PRNewswire/ — On April 28, 2025, Woori Financial Group Inc. (NYSE:WF) (KRX:316140) filed its Annual Report on Form 20-F...

JCET Reports Q1 2025 Revenue Growth of 36.4% and Net Profit Growth of 50.4%

Q1 2025 Financial Highlights: Q1 revenue of RMB 9.34 billion, a 36.4% increase year-on-year, marking a record high for the same period. Q1 net profit...

Jianpu Technology Inc. Files 2024 Annual Report on Form 20-F

BEIJING, April 28, 2025 /PRNewswire/ — Jianpu Technology Inc. (“Jianpu” or the “Company”) (OTCQB: AIJTY), a leading open financial technology platform in China, today announced...

Health In Tech’s CEO Tim Johnson Discusses Company in 2025, Revenue Growth, and Healthcare on “The Street Reports Podcast” Listen Now!

STUART, Fla., April 28, 2025 /PRNewswire/ — Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is proud to share that...

JCET Reports Q1 2025 Revenue Growth of 36.4% and Net Profit Growth of 50.4%

Q1 2025 Financial Highlights: Q1 revenue of RMB 9.34 billion, a 36.4% increase year-on-year, marking a record high for the same period. Q1 net profit...